drugset / Trial / NCT02224144

Bone Mass and Strength After Kidney Transplantation

NCT02224144

Phase 2 Completed 61 enrolled Columbia University Satellite Healthcare · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to test whether active vitamin D (calcitriol) protects bones from weakening and protects blood vessels from calcium deposits over the first year of kidney transplantation.

Timeline

Start
2014-08-18
Primary completion
2016-10-12
Completion
2016-10-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule 0.5 ug Oral
Background Cholecalciferol Other / unclassified 1000 iu Oral